Literature DB >> 21253686

[Lung cancer staging].

C Hintze1, J Dinkel, J Biederer, C P Heussel, M Puderbach.   

Abstract

Lung cancer is the third most frequent new cancer diagnosis in Germany. An elaborate clinical diagnosis is essential for successful therapy planning. The necessary examinations are defined in the current S3 guideline on lung cancer diagnosis and therapy. A compilation of diagnostic reports has led to the current 7th edition of the TNM system. According to this update staging is carried out in terms of tumor extent, lymph node status and distant metastases. The resultant tumor stage forms the basis for individual therapy planning. Current guidelines as well as the current TNM system are presented. The usefulness of modern cross-sectional imaging and the possible modalities in this system is reported.

Entities:  

Mesh:

Year:  2011        PMID: 21253686     DOI: 10.1007/s00117-010-2112-8

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  11 in total

1.  A hybrid breath hold and continued respiration-triggered technique for time-resolved 3D MRI perfusion studies in lung cancer.

Authors:  C Hintze; A Stemmer; M Bock; T A Kuder; F Risse; J Dinkel; H Prüm; M Puderbach; C Fink; J Biederer; H-U Kauczor
Journal:  Rofo       Date:  2009-10-26

Review 2.  [Endobronchial ultrasound].

Authors:  D Gompelmann; R Eberhardt; F J F Herth
Journal:  Radiologe       Date:  2010-08       Impact factor: 0.635

Review 3.  [New procedures. Comprehensive staging of lung cancer by MRI].

Authors:  C Hintze; J Dinkel; J Biederer; C P Heussel; M Puderbach
Journal:  Radiologe       Date:  2010-08       Impact factor: 0.635

Review 4.  [Epidemiology of lung cancer].

Authors:  N Becker
Journal:  Radiologe       Date:  2010-08       Impact factor: 0.635

Review 5.  [Conventional and CT diagnostics of bronchial carcinoma].

Authors:  C Schaefer-Prokop
Journal:  Radiologe       Date:  2010-08       Impact factor: 0.635

Review 6.  [Lung cancer from the perspective of internal medicine and surgery].

Authors:  A Prasse; C Waller; B Passlick; J Müller-Quernheim
Journal:  Radiologe       Date:  2010-08       Impact factor: 0.635

Review 7.  [PET/CT for diagnostics and therapy stratification of lung cancer].

Authors:  C Kratochwil; U Haberkorn; F L Giesel
Journal:  Radiologe       Date:  2010-08       Impact factor: 0.635

8.  Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.

Authors:  Daisuke Takenaka; Yoshiharu Ohno; Keiko Matsumoto; Nobukazu Aoyama; Yumiko Onishi; Hisanobu Koyama; Munenobu Nogami; Takeshi Yoshikawa; Sumiaki Matsumoto; Kazuro Sugimura
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

9.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

10.  Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.

Authors:  Yoshiharu Ohno; Hisanobu Koyama; Yumiko Onishi; Daisuke Takenaka; Munenobu Nogami; Takeshi Yoshikawa; Sumiaki Matsumoto; Yoshikazu Kotani; Kazuro Sugimura
Journal:  Radiology       Date:  2008-06-06       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.